The scientific posters presented by mjn-neuro over the years reflect our team's ongoing commitment to research and advancing knowledge in neurological diseases, especially epilepsy. Each poster is a concise visual summary of the results obtained in different projects or studies, allowing us to share our findings in an accessible and effective way at congresses and conferences.
2023
Title
Congress
Links
Artificial intelligence system, based on mjn-SERAS algorithm, for early detection of seizures in patients with refractory focal epilepsy: a crosssectional pilot study.
1st International Conference on Artificial Intelligence in Epilepsy and Neurological disorders. (Colorado - USA)
Validation of medical device mjn-SERAS for early detection of epileptic seizures in refractory epilepsy patients in a normalised environment: A prospective, multicentre, pilot clinical study protocol.
1st International Conference on Artificial Intelligence in Epilepsy and Neurological disorders. (Colorado - USA)
Artificial intelligence system, based on mjn-SERAS algorithm, for early detection of seizures in patients with refractory focal epilepsy: a crosssectional pilot study.
4th International Congress on mobile Health and digital technology in Epilepsy. (MHDTEpilepsy Lausanne)
Validation of medical device mjn-SERAS for early detection of epileptic seizures in refractory epilepsy patients in a normalised environment: A prospective, multicentre, pilot
4th International Congress on mobile Health and digital technology in Epilepsy. (MHDTEpilepsy Lausanne)
mjn-SERAS device, long-term EEG recording and seizure forecasting.
4th International Congress on mobile Health and digital technology in Epilepsy. (MHDTEpilepsy Lausanne)
AI technology for seizure forecasting.
4th International Congress on mobile Health and digital technology in Epilepsy. (MHDTEpilepsy Lausanne)
2024
Title
Congress
Links
Day-to-day life impact of the early seizure detection, using forecasting models in real time with mjn-SERAS device.
2nd International Conference on Artificial Intelligence in Epilepsy and Neurological disorders (USA)
